08/07/2026
Clean eating and exercise is the way. Itβs also much more rewarding seeing the results of your own work. πͺπ»
π¨ Hundreds of deaths suspected of being linked to weight-loss jabs have been reported to UK regulators, and the numbers are raising serious questions about these highly profitable drugs.
According to the latest figures from the Medicines and Healthcare products Regulatory Agency (MHRA), more than 200 deaths have been flagged as connected to popular GLP-1 weight-loss injections, alongside a staggering 158,000-plus reports of adverse reactions.
These include everything from severe gastrointestinal issues to other serious side effects.
Breaking it down:
Tirzepatide (sold as Mounjaro) accounts for the largest share, with 106,189 adverse reactions and 120 deaths reported.
Semaglutide, the active ingredient in Wegovy as well as the diabetes treatments Ozempic and Rybelsus, has been linked to 48,089 reactions and 59 deaths.
Liraglutide (Saxenda) comes in with 4,491 reactions and 37 deaths.
These figures come through the MHRAβs Yellow Card Scheme, the official and only system in place for reporting suspected side effects from medicines.
Patients, doctors and family members submit these reports when they believe a drug is responsible, making the data a critical and valid record of real-world harm.
Health Secretary Yvette Cooper has pointed to the monitoring systems within the NHS and among expert regulators, stressing that safety remains paramount.
Yet these medications continue as blockbuster money-makers for their manufacturers even as the volume of serious reports climbs.
For many people, the simpler, proven approach of consistent diet and exercise, when done correctly, delivers lasting results without the potential for severe side effects or the need for ongoing injections.
These drugs have helped some achieve rapid weight loss, but the scale of reported deaths and reactions makes the risks impossible to overlook.